Debt to Equity Ratio Chart

View Debt to Equity Ratio for SCND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.0979
March 31, 2026 0.0969
December 31, 2025 0.0907
September 30, 2025 0.0658
June 30, 2025 0.1143
March 31, 2025 0.127
December 31, 2024 0.1098
September 30, 2024 0.0996
June 30, 2024 0.0998
March 31, 2024 0.0989
December 31, 2023 0.0959
March 31, 2023 0.1038
December 31, 2022 0.0969
September 30, 2022 0.0641
June 30, 2022 0.0602
March 31, 2022 0.0572
December 31, 2021 0.068
September 30, 2021 0.0442
June 30, 2021 0.0567
March 31, 2021 0.1691
December 31, 2020 0.1482
September 30, 2020 0.1369
June 30, 2020 0.1232
March 31, 2020 0.1548
December 31, 2019 0.1577
Date Value
September 30, 2019 0.1551
June 30, 2019 0.0221
March 31, 2019 0.0084
December 31, 2018 0.0004
September 30, 2018 0.0007
June 30, 2018 0.001
March 31, 2018 0.0086
December 31, 2017 0.0089
September 30, 2017 0.0019
June 30, 2017 0.0021
March 31, 2017 0.0024
December 31, 2016 0.0452
September 30, 2016 0.0029
June 30, 2016 0.0032
March 31, 2016 0.2032
December 31, 2015 0.1159
September 30, 2015 0.0703
June 30, 2015 0.0348
March 31, 2015 0.0184
December 31, 2014 0.0463
September 30, 2014 0.0373
December 31, 2013 0.0214
June 30, 2013 0.0195
March 31, 2013 0.0237
September 30, 2012 0.0545

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Accuray, Inc. 4.410
Orthofix Medical, Inc. 0.6102
ResMed, Inc. 0.1254
Rockwell Medical, Inc. 0.3971
Microbot Medical, Inc. 0.0127